Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7107396rdf:typepubmed:Citationlld:pubmed
pubmed-article:7107396lifeskim:mentionsumls-concept:C0018555lld:lifeskim
pubmed-article:7107396lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:7107396lifeskim:mentionsumls-concept:C0024071lld:lifeskim
pubmed-article:7107396lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:7107396lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:7107396lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:7107396pubmed:issue3-4lld:pubmed
pubmed-article:7107396pubmed:dateCreated1982-10-12lld:pubmed
pubmed-article:7107396pubmed:abstractTextThe interaction of lucanthone and cyclophosphamide (CYC) was investigated in the Chinese hamster in terms of the LD50/7 and LD50/30. These values may be indicative of gastrointestinal stem cell depletion and bone marrow stem cell depletion, respectively. When a nonlethal dose of 100 mg/kg lucanthone preceded CYC injection, the LD50/7 for CYC reached its minimum value of 470 mg/kg at a treatment interval of 10 hours. Lucanthone administered simultaneously with CYC had no effect on the control LD50/7 of 750 mg/kg, and by 48 hours after lucanthone administration the LD50/7 had returned to the control value. When CYC administration preceded that of lucanthone, the LD50/7 reached a minimum of value of 610 mg/kg at an interval of 5 hours; however, for the entire sequence it was approximately 640 mg/kg over all intervals up to 48 hours. The LD50/30 for CYC was only slightly reduced by the presence of lucanthone, indicating that bone marrow sensitivity to CYC was only marginally affected by lucanthone. These data indicate that lucanthone may interact with CYC damage in much the same way as it interacts with radiation damage, viz, by reducing cellular capacity to accumulate and repair sublethal damage.lld:pubmed
pubmed-article:7107396pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7107396pubmed:languageenglld:pubmed
pubmed-article:7107396pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7107396pubmed:citationSubsetIMlld:pubmed
pubmed-article:7107396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7107396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7107396pubmed:statusMEDLINElld:pubmed
pubmed-article:7107396pubmed:issn0360-3016lld:pubmed
pubmed-article:7107396pubmed:authorpubmed-author:LeeperD BDBlld:pubmed
pubmed-article:7107396pubmed:authorpubmed-author:WhittingtonRRlld:pubmed
pubmed-article:7107396pubmed:authorpubmed-author:MilliganA JAJlld:pubmed
pubmed-article:7107396pubmed:issnTypePrintlld:pubmed
pubmed-article:7107396pubmed:volume8lld:pubmed
pubmed-article:7107396pubmed:ownerNLMlld:pubmed
pubmed-article:7107396pubmed:authorsCompleteYlld:pubmed
pubmed-article:7107396pubmed:pagination667-70lld:pubmed
pubmed-article:7107396pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:meshHeadingpubmed-meshheading:7107396-...lld:pubmed
pubmed-article:7107396pubmed:articleTitleLucanthone modification of cyclophosphamide toxicity in the Chinese hamster.lld:pubmed
pubmed-article:7107396pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7107396pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed